Welcome to vpod.ai’s The Deep Dive, proudly sponsored by StoneFly. In this episode, we explore the complex, often misunderstood world of neuroendocrine tumors (NETs)—from silent symptoms to cutting-edge treatments revolutionizing outcomes.
You'll learn:
- What NETs are, where they originate, and why the term “carcinoid” is outdated
- How carcinoid syndrome causes symptoms like flushing, diarrhea, and heart issues
- The step-by-step diagnostic process, from biomarkers to biopsy
- Why surgery remains vital—and what’s next when surgery isn’t enough
- Advances in somatostatin analogs, Everolimus, and targeted therapies
- Game-changers like CAR-T cell therapy, new immunotherapy combinations, and anti-angiogenesis drugs
- How the latest FDA approvals are reshaping care for advanced and aggressive NETs
This is the frontline of rare cancer research—where collaboration, innovation, and precision medicine are making a real difference.
What is Vpod.ai?
VPod is your go-to podcast platform for unfiltered conversations about real life. From personal journeys and societal issues to career insights and everyday experiences, we dive deep into the topics that matter. No scripts, no fluff—just real stories, real people, and real talk. Tune in and explore life from every angle.